Floatz logo

Epinephrine

Inferior Alveolar Nerve Injuries

Cleveland Dental InstituteSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Inferior Alveolar Nerve Injuries cohort.

Asset / SponsorPhaseRating
LIDOCAINE
Cleveland Dental Institute
Phase 1CCC
ARTICAINE
Cleveland Dental Institute
Phase 1CC
Rvp-001
Reveal Pharmaceuticals Inc.
Phase 2NR
Acetylsalicylic Acid
Loma Linda University
Phase 4NR

Same molecule, other indications

Epinephrine is also rated in:

Pain, PostoperativeDormant
BBB
Indicative ·
72 / 100
View asset →
digestive system disorderDormant
BB
Indicative ·
68 / 100
View asset →
Crohn diseaseDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →